Biora Therapeutics, Inc.

BIOR · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$124-$38-$179-$193
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$22$59
Stock-Based Comp.$16$8$12$8
Change in WC$9-$5-$26-$51
Other Non-Cash$50-$30$2$10
Operating Cash Flow-$48-$64-$167-$166
Investing Activities
PP&E Inv.-$0-$1-$1-$5
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$3$0-$0$0
Investing Cash Flow$2-$1-$1-$5
Financing Activities
Debt Repay.$10-$0-$2$99
Stock Issued$18$9$47$116
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3-$2$120$14
Financing Cash Flow$31$7$165$230
Forex Effect$0$0$0$0
Net Chg. in Cash-$15-$58-$4$59
Supplemental Information
Beg. Cash$30$88$92$33
End Cash$15$30$88$92
Free Cash Flow-$49-$65-$168-$171
Biora Therapeutics, Inc. (BIOR) Financial Statements & Key Stats | AlphaPilot